New coverage provided by Youm7 TV, prepared by Hadeel Al-Banna, and presented by Hisham Abdel Tawab, about the discovery of a new drug that treats rectal cancer, after it was tested on and proven effective on 18 people.
Publish a site ” ndtv” And “The New York Times”, news that represents new hope for patients with rectal cancer, as 18 patients with rectal cancer were given the drug “dostarlimab” for six months and as a result of the treatment, the cancer was completely eliminated in each patient.
It is commonly used in the treatment of endometrial cancer, but this was the first clinical test of whether it was also effective against rectal cancer tumors, and indeed it has been shown to be effective in treating the malignant disease..
This drug contains molecules produced in the laboratory that act as alternative antibodies in the human body, 18 rectal cancer patients were given the same drug, and as a result of the treatment, the cancer was completely eliminated in each patient.
This was “the first time this has happened in the history of cancer,” said Dr. Luis Diaz, Jr. of Memorial Sloan Kettering Cancer Center in New York.“.
Early results indicated that the treatment is effectively effective, as the research team explained that it may be the first experience during which all cancer patients are cured.
Separately, Memorial Sloan Kettering Cancer Center and paper co-author, oncologist Dr Andrea Krecic, described the moment patients discovered they were cancer-free and told the New York Times: “There were a lot of tears of joy.”“.
For the trial, patients took dostarlimab every three weeks for six months, and all of them were in advanced stages of cancer – it was in the rectum but had not spread to other organs..
Cancer researchers who reviewed the drug said the treatment offers hope for patients with rectal cancer, but that a large-scale trial is needed to see if it works in more patients and if the cancers are already recovering..